Morning Overview on MSN
A Harvard scientist says his team is preparing the first human trials aimed at reversing aging
A team linked to Harvard Medical School has dosed the first patient in a clinical trial designed to reverse cellular aging in ...
However,instead of attacking cancer cells, they are typically co-opted to support tumor growth, metastasis, and therapeutic ...
Cancer cells are quick to develop resistance to anti-tumor drugs. New research by scientists from the University of ...
Blindness itself might become, at least in certain cases, partially reversible. This potential future stems from one of the ...
Plant regeneration represents a cornerstone of modern plant science, blending fundamental questions in developmental biology ...
Signal transduction and gene regulation are at the heart of cell and developmental biology, driving cell fate decisions and tissue homeostasis. In cancer, ...
The V.I. Public Finance Authority board on Thursday approved a $1.5 million payment to the V.I. Port Authority, following ...
The technology that gave the world mRNA COVID vaccines is being tested in a variety of new ways, and emerging research ...
TAIPEI, June 23, 2026 /PRNewswire/ -- Sparkling Sciences Co., Ltd., under TOMO YUME Group, announced it has obtained international INCI certification for iPSC Exosome and completed Kyoto University's ...
Novel immune reprogramming oral macrocyclic peptides designed for precise modulation of complex biological networks involved in inflammatory, ...
Researchers are decoding how signals move between body and brain, with implications for how we understand and treat ...
Proprietary Synthetic Polynucleotide Platform Accelerates Non-Viral, Footprint-Free Induced Pluripotent Stem Cell Generation Amid Surging Commercialization of iPSC Therapies in Japan SEATTLE, June 16, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results